QTTB Q32 Bio Inc.

Fundamentals / CIK 0001661998 / USD

Q32 Bio Inc. reported $53.74M in revenue and net income of $32.25M for the fiscal year ended December 31, 2025, with a 34.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open QTTB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$66.55M$33.28M$0-$124.9MFY 2017 Net Income: -$29.99M2017FY 2018 Revenue: $3.68MFY 2018 Net Income: -$55.58M2018FY 2019 Revenue: $1.67MFY 2019 Net Income: -$103.9M2019FY 2020 Revenue: $2.70MFY 2020 Net Income: -$128.7M2020FY 2021 Revenue: $33.97MFY 2021 Net Income: -$95.76M2021FY 2022 Revenue: $3.21MFY 2022 Net Income: -$5.00M2022FY 2023 Revenue: -$6.65MFY 2023 Net Income: -$53.74M2023FY 2024 Revenue: $0FY 2024 Net Income: -$47.73M2024FY 2025 Revenue: $53.74MFY 2025 Net Income: $29.82M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $53.74M $0 -$6.65M $3.21M $33.97M $2.70M $1.67M $3.68M --
Research & Development $19.16M $48.14M $31.73M $98.35M $93.08M $100.4M $89.40M $47.95M $21.38M
Total Operating Expenses $36.84M $66.10M $41.60M $136.5M $129.9M $133.0M $111.6M $65.25M $29.66M
Operating Income $16.90M -$66.10M -$48.26M -$133.3M -$95.95M -$130.3M -$109.9M -$59.93M -$29.66M
EBITDA $17.29M -$65.61M -$47.76M -$132.0M -$87.60M -$122.3M -$103.6M -$58.64M -$28.97M
Interest Expense -- -- $1.50M -- -- -- -- -- --
Income Before Tax $29.82M -$46.09M -$87.08M $1.20M -$95.76M -- -- -- --
Income Tax Expense $0 $21K $318K $715K $0 $0 $0 $0 $0
Net Income $29.82M -$47.73M -$53.74M -$5.00M -$95.76M -$128.7M -$103.9M -$55.58M -$29.99M
Basic EPS $2.42 -$5.12 -$153.96 -$0.09 -$1.73 -$2.80 -$2.47 -$1.95 -$12.10
Diluted EPS $2.42 -$6.58 -$153.96 -$0.09 -$1.73 -$2.80 -$2.47 -$1.95 -$12.10
Basic Shares Outstanding 12.3M 9.3M 349.1K 57.4M 55.3M 45.9M 42.1M 28.6M 2.5M
Diluted Shares Outstanding 12.3M 9.7M 349.1K 57.4M 55.3M 45.9M 42.1M 28.6M 2.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- -- -- -- $0
Research & Development $5.15M $4.26M $3.22M $3.31M $3.56M $5.16M $7.12M $10.54M
Total Operating Expenses $10.66M $9.12M $7.72M $7.86M $7.58M $9.17M $12.23M $14.53M
Operating Income -$10.66M -$9.12M -$7.72M $45.88M -$7.58M -$9.17M -$12.23M -$14.53M
EBITDA -$10.56M -$9.02M -$7.63M $45.97M -$7.48M -$9.07M -$12.11M -$14.41M
Income Before Tax -- -- -- $57.73M -$7.39M -$9.49M -$11.03M -$14.17M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $21K
Net Income -$8.92M -$8.95M -$7.61M $57.73M -$7.39M -$9.49M -$11.03M -$14.19M
Basic EPS -$0.26 -$0.44 -$0.54 -- -$0.60 -$0.78 -$0.90 --
Diluted EPS -$0.26 -$0.44 -$0.54 -- -$0.60 -$0.78 -$0.90 --
Basic Shares Outstanding 34.0M 20.3M 14.1M -- 12.2M 12.2M 12.2M --
Diluted Shares Outstanding 34.0M 20.3M 14.1M -- 12.2M 12.2M 12.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $48.30M $77.97M $25.62M $33.99M $108.4M $217.4M $53.77M $38.22M $51.58M
Short-Term Investments -- $0 $0 $141.0M $47.49M $0 $208.6M $176.5M $78.08M
Cash & Short-Term Investments $48.30M $77.97M $25.62M $175.0M $155.9M $217.4M $262.4M $214.7M $129.7M
Other Current Assets $20K $396K $83K -- -- -- -- -- --
Total Current Assets $55.05M $81.88M $28.72M $181.0M $191.9M $219.6M $266.6M $221.7M $131.6M
Property, Plant & Equipment, Net $979K $1.37M $1.78M $1.08M $2.25M $37.00M $42.72M $35.64M $3.15M
Other Non-Current Assets $0 $116K $4.61M -- -- -- -- -- --
Total Non-Current Assets $6.73M $10.46M $18.34M $47.45M $19.81M $44.17M $43.99M $37.41M $5.93M
Total Assets $61.78M $92.33M $47.06M $228.5M $211.7M $263.7M $310.6M $259.1M $137.5M
Accounts Payable $879K $2.99M $3.47M $1.14M $2.37M $4.72M $2.61M $15.73M $2.54M
Deferred Revenue (Current) -- -- $0 $1.16M $3.21M $5.63M $809K $770K $3.34M
Total Current Liabilities $11.35M $16.46M $14.11M $22.58M $17.23M $22.66M $12.37M $22.52M $8.86M
Deferred Revenue (Non-Current) -- -- -- $0 $1.16M $32.14M $30.14M $30.75M $30.07M
Other Non-Current Liabilities $0 $55.00M $55.00M -- -- -- -- -- --
Total Non-Current Liabilities $8.42M $70.19M $104.4M $27.92M $24.84M $45.08M $39.69M $40.22M $30.36M
Total Liabilities $19.76M $86.66M $118.5M $50.49M $42.07M $67.74M $52.06M $62.74M $39.22M
Total Debt (incl. Leases) $5.64M $6.25M $6.79M $29.48M $23.93M $15.44M -- -- --
Common Stock $2.0K $2.0K $1.0K $6.0K $6.0K $5.0K $4.0K $3.0K $264
Retained Earnings -$205.0M -$234.8M -$187.1M -$429.1M -$424.1M -$328.4M -$199.7M -$95.76M -$40.18M
Accumulated Other Comp. Income -- $0 $0 -$404K -$7.0K $0 $183K -$77K -$73K
Total Stockholders' Equity $42.01M $5.67M -$182.9M -$130.7M $169.7M $196.0M $258.5M $196.4M -$39.45M
Total Equity $42.01M $5.67M -$182.9M -$130.7M $169.7M $196.0M $258.5M $196.4M -$39.45M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $289.6M $106.3M $50.75M $48.30M $49.04M $54.83M $65.48M $77.97M
Short-Term Investments -- -- -- -- -- -- -- $0
Cash & Short-Term Investments $289.6M $106.3M $50.75M $48.30M $49.04M $54.83M $65.48M $77.97M
Other Current Assets $19K $19K $20K $20K $24K $77K $93K $396K
Total Current Assets $291.1M $109.6M $57.20M $55.05M $50.81M $58.32M $68.63M $81.88M
Property, Plant & Equipment, Net $827K $804K $889K $979K $1.07M $1.16M $1.25M $1.37M
Other Non-Current Assets -- -- -- $0 $0 $570K $444K $116K
Total Non-Current Assets $6.08M $6.22M $6.47M $6.73M $6.97M $7.79M $10.44M $10.46M
Total Assets $297.2M $115.9M $63.67M $61.78M $57.78M $66.12M $79.07M $92.33M
Accounts Payable $1.11M $1.56M $653K $879K $973K $910K $2.71M $2.99M
Total Current Liabilities $5.17M $5.40M $10.67M $11.35M $11.11M $11.53M $14.58M $16.46M
Other Non-Current Liabilities -- -- -- $0 $55.00M $55.00M $55.00M $55.00M
Total Non-Current Liabilities $4.36M $4.56M $6.69M $8.42M $65.12M $66.82M $68.51M $70.19M
Total Liabilities $9.53M $9.96M $17.36M $19.76M $76.23M $78.35M $83.08M $86.66M
Total Debt (incl. Leases) $5.12M $5.30M $5.47M $5.64M $5.79M $5.95M $6.10M $6.25M
Common Stock $3.0K $3.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K
Retained Earnings -$230.5M -$221.5M -$212.6M -$205.0M -$262.7M -$255.3M -$245.8M -$234.8M
Accumulated Other Comp. Income -- -- -- -- $0 $0 $0 $0
Total Stockholders' Equity $287.7M $105.9M $46.31M $42.01M -$18.45M -$12.23M -$4.01M $5.67M
Total Equity $287.7M $105.9M $46.31M $42.01M -$18.45M -$12.23M -$4.01M $5.67M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $29.82M -$47.73M -$113.0M -$5.00M -$95.76M -$128.7M -$103.9M -$55.58M -$29.99M
Depreciation & Amortization $391K $487K $499K $1.29M $8.35M $7.96M $6.32M $1.29M $684K
Stock-Based Compensation $5.25M $4.39M $1.43M $13.05M $17.25M $13.25M $7.63M $2.62M $277K
Change in Payables -$2.11M -$1.04M $2.03M -$981K -$2.49M $2.46M -$4.45M $4.38M $1.72M
Operating Cash Flow -$33.54M -$67.72M -$18.68M -$113.7M -$109.8M -$94.33M -$91.36M -$42.56M $6.48M
Capital Expenditure $0 -$75K -$5.0K -$1.28M -$2.40M -$3.73M -$21.83M -$24.94M -$1.96M
Free Cash Flow -$33.54M -$67.79M -$18.68M -$114.9M -$112.1M -$98.06M -$113.2M -$67.50M $4.52M
Purchases of Investments -- -- -$73.24M -$157.5M -$97.39M -$19.99M -$286.4M -$245.3M -$78.07M
Investing Cash Flow $7.00M $19.93M -$5.0K $36.72M -$50.79M $204.9M -$51.80M -$121.8M -$81.53M
Common Stock Issued $0 $42.00M $0 $0 $49.74M -- $134.5M -- --
Financing Cash Flow -$3.12M $95.14M $406K $596K $52.17M $53.09M $158.2M $151.0M $115.2M
Net Change in Cash -$29.67M $47.35M $5.28M -$76.35M -$108.4M $163.7M $15.06M -$13.36M $40.18M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$8.92M -$8.95M -$7.61M $57.73M -$7.39M -$9.49M -$11.03M -$14.19M
Depreciation & Amortization $100K $100K $90K $90K $100K $100K $119K $120K
Stock-Based Compensation $2.90M $1.69M $1.55M $1.47M $1.18M $1.27M $1.34M $1.25M
Change in Payables -$476K $912K -$226K -$94K $63K -$1.80M -$277K $1.73M
Operating Cash Flow -$4.42M -$3.08M -$6.34M -$6.18M -$4.23M -$10.65M -$12.48M -$11.43M
Capital Expenditure -- -- -- -- -- -- -- -$2.0K
Free Cash Flow -- -- -- -- -- -- -- -$11.43M
Investing Cash Flow -$52K $0 $0 $7.00M $0 $0 $0 -$2.0K
Common Stock Issued $0 $0 $10.36M $0 $0 $0 $0 $0
Financing Cash Flow $187.8M $58.59M $8.80M -- -- -- -- $317K
Net Change in Cash $183.3M $55.52M $2.45M -$742K -$5.79M -$10.65M -$12.48M -$11.11M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin 31.5% -- -- -4154.6% -282.4% -4821.0% -6599.2% -1626.7% --
Net Profit Margin 55.5% -- -- -156.0% -281.9% -4762.9% -6237.5% -1508.6% --
Return on Equity (ROE) 71.0% -841.1% -- -- -56.4% -65.7% -40.2% -28.3% --
Return on Assets (ROA) 48.3% -51.7% -114.2% -2.2% -45.2% -48.8% -33.5% -21.5% -21.8%
Current Ratio 4.85x 4.97x 2.04x 8.02x 11.14x 9.69x 21.54x 9.84x 14.85x
Quick Ratio 4.26x 4.74x 1.82x 7.75x 9.05x 9.60x 21.20x 9.54x 14.63x
Debt to Equity 0.13x 1.10x -- -- 0.14x 0.08x -- -- --
Revenue Growth (YoY) -- -- -307.3% -90.6% +1157.3% +62.2% -54.8% -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -756.9% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -1593.1% --
5Y Revenue / Share Growth +7323.0% -100.0% -14867.3% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) 11.2% 31.9% 71.8% 71.0% -- -- -- -841.1%
Return on Assets (ROA) 10.9% 29.2% 52.2% 48.3% -72.9% -79.1% -75.6% -51.7%
Current Ratio 56.34x 20.30x 5.36x 4.85x 4.57x 5.06x 4.71x 4.97x
Quick Ratio 56.05x 19.68x 4.76x 4.26x 4.41x 4.75x 4.49x 4.74x
Debt to Equity 0.02x 0.05x 0.12x 0.13x -- -- -- 1.10x
Net Income Growth (YoY) -- -- -- -- -- -- -1172.0% --
EPS Growth (YoY) -- -- -- -- -- -- -187.4% --
Source: SEC EDGAR CompanyFacts (CIK 0001661998) · from March 31, 2017 Data through September 30, 2026 · synced Nov 20, 2026, 05:41 UTC · Open in terminal